Francisco Chacón-Lozsán/LinkedIn
Mar 22, 2026, 14:46
Francisco Chacón-Lozsán: PE Is The New STEMI, But Are We Treating It Too Aggressively?
Francisco Chacón-Lozsán, Fellow at World Extreme Medicine, Member of European Society of Intensive Care Medicine (ESICM) and American College of Cardiology, shared on LinkedIn:
”’PE is the new STEMI’ — but are we treating it too aggressively?
One of the most thought-provoking sessions at ACVC26 challenged the growing enthusiasm for catheter-directed therapies.
The message was clear:
- Not every PE needs intervention
- In fact, most patients do well with anticoagulation alone
- The real challenge is not how to treat – but who to treat.
Current risk scores don’t capture the full picture
More evidence is underway.
We need to move toward:
- Better understanding of RV failure
- Early identification of decompensation
- Truly individualized decision-making
Until then: Avoid ‘wild’ use of catheter-based therapies”
Stay updated with Hemostasis Today.
-
Mar 22, 2026, 14:26Hussien Hishmat: Pulmonary Embolism – How Does Risk Dictate Management
-
Mar 22, 2026, 14:12Bruno Pougault: Oral Anticoagulants Are Essential, But Not a ‘Fix-All’
-
Mar 22, 2026, 13:58Erwin Loh: AI-Assisted Stroke Tool Linked to Better Patient Outcomes
-
Mar 22, 2026, 13:05Christina Mansour: Shifting Aortic Stenosis Care Toward a Lifetime Management Strategy
-
Mar 22, 2026, 13:01Juan Lama: New HIV Cure Approach Forces Hidden Virus into Tripping Immune Sensor
-
Mar 22, 2026, 12:48María Florencia Giannini: Diagnosis and Management of VTE in Pregnancy and Postpartum
-
Mar 22, 2026, 12:47Eishi Asano: Improving Extremity Motor Function in A Chronic Basal Ganglia Stroke with VLp-Targeted Ultrasound
-
Mar 22, 2026, 12:38Ananya Gupta: How Platelets and Megakaryocytes Remodel the Lung Matrix After Injury
-
Mar 22, 2026, 12:32Sekyi-Brown Reginald: Ghana Should Include Alteplase and Tenecteplase in National Health Insurance